Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · IEX Real-Time Price · USD
105.55
-0.84 (-0.79%)
Jun 14, 2024, 4:00 PM EDT - Market closed

Blueprint Medicines Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2013
Cash & Equivalents
81.52124.9215.12689.8119.1
Upgrade
Short-Term Investments
639.36825.28267.17187.21369.62
Upgrade
Cash & Cash Equivalents
720.88950.19482.29877.02488.72
Upgrade
Cash Growth
-24.13%97.02%-45.01%79.45%-2.09%
Upgrade
Receivables
42.8336.9437.0325.3123.41
Upgrade
Inventory
21.2229.721.828.580
Upgrade
Other Current Assets
23.4629.8312.8916.854.65
Upgrade
Total Current Assets
808.391,047554.03927.76516.79
Upgrade
Property, Plant & Equipment
115.65115.2120.86101.67111.11
Upgrade
Long-Term Investments
84.32161.27557.53677.8764.41
Upgrade
Other Long-Term Assets
40.8926.7819.8111.0915.39
Upgrade
Total Long-Term Assets
240.86303.25698.2790.63190.91
Upgrade
Total Assets
1,0491,3501,2521,718707.69
Upgrade
Accounts Payable
4.712.738.334.374.79
Upgrade
Deferred Revenue
5.618.2936.5841.1646.07
Upgrade
Current Debt
42.2127.438.097.946.82
Upgrade
Other Current Liabilities
162.4134.7896.7677.3448.79
Upgrade
Total Current Liabilities
214.92183.23149.77130.8106.48
Upgrade
Long-Term Debt
290.29215.02103.3281.6789.13
Upgrade
Other Long-Term Liabilities
413.43436.9728.4135.8347.73
Upgrade
Total Long-Term Liabilities
703.72651.99131.73117.5136.85
Upgrade
Total Liabilities
918.64835.23281.49248.31243.34
Upgrade
Total Debt
332.5242.45111.4189.695.95
Upgrade
Debt Growth
37.14%117.62%24.33%-6.61%-
Upgrade
Retained Earnings
-2,339.94-1,832.96-1,275.44-631.36-945.24
Upgrade
Comprehensive Income
-3.5-10.44-4.13-5.21-2.54
Upgrade
Shareholders' Equity
130.61514.68970.741,470464.36
Upgrade
Net Cash / Debt
388.38707.74370.88787.41392.77
Upgrade
Net Cash / Debt Growth
-45.12%90.83%-52.90%100.48%-21.31%
Upgrade
Net Cash Per Share
6.4111.876.3414.028.21
Upgrade
Working Capital
593.47863.42404.26796.96410.3
Upgrade
Book Value Per Share
2.168.6316.5926.969.71
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).